| Structure |
Chemical Name |
CAS |
MF |
 |
Loratadine Impurity 19 |
79779-58-1 |
C22H24N2O2 |
 |
(Z)-2-chloro-3-hydroxyacrylaldehyde |
50704-42-2 |
C3H3ClO2 |
![(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4''-fluoro-[1,1''-biphenyl]-4-yl)-1-methylpiperidine hydrochloride](/) |
(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4''-fluoro-[1,1''-biphenyl]-4-yl)-1-methylpiperidine hydrochloride |
|
|
|
|
Ticagrelor Related Compound 39 |
|
|
|
|
Erlotinib Impurity 32 |
|
|
|
|
Pramipexole Impurity 36 |
|
|
|
|
Teneligliptin Impurity 3 |
|
|
|
|
Erlotinib Hydrochloride iMpurity 52 |
|
|
 |
Ornidazole Impurity J |
742020-47-9 |
C7H12N4O3 |
 |
Androstan-17-one,2,3-epoxy-16-(1-pyrrolidinyl) |
159325-45-8 |
C23H35NO2 |
|
|
Tofacitinib Impurity 35 |
|
|
 |
ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate |
1884279-18-8 |
C18H17NO4S |
 |
N-methyl-1-(5-phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methanamine fumarate |
928325-82-0 |
C17H17N3O2S.C4H4O4 |
 |
2,4-ジブロモ-m-クレゾール |
13321-75-0 |
C7H6Br2O |
 |
N-((4-フルオロフェニル)メチル)エタンアミド |
86010-68-6 |
C9H10FNO |
 |
Benzenediazonium, 4-(ethoxycarbonyl)-, chloride |
2028-79-7 |
C9H9ClN2O2 |
 |
2,4-Pteridinediamine,6-(methoxymethyl)- |
40110-13-2 |
C8H10N6O |
 |
Fingolimod EP Impurity D |
780729-32-0 |
C21H37NO2 |
 |
Pentanedioic acid, 2,4-diacetyl-3-(3-nitrophenyl)-, dimethyl ester |
89080-61-5 |
C17H19NO8 |
![2-Thiazoleacetic acid,4-carboxy-2,5-dihydro-5-(4-hydroxybutylidene)-a-[(1R)-1-hydroxyethyl]-, disodium salt, (aS,2R,5Z)- (9CI)](/CAS/20180808/GIF/130609-10-8.gif) |
2-Thiazoleacetic acid,4-carboxy-2,5-dihydro-5-(4-hydroxybutylidene)-a-[(1R)-1-hydroxyethyl]-, disodium salt, (aS,2R,5Z)- (9CI) |
130609-10-8 |
C12H18NNaO6S |
 |
4,4'-Iminodiphenol hydrochloride |
1965310-24-0 |
C12H12ClNO2 |
|
|
Cefradine Impurity D |
|
|
 |
Donepezil Impurity |
896134-06-8 |
C17H15NO4 |
 |
1-(2-chloro-5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine |
928325-68-2 |
C17H15ClFN3O2S |
 |
N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide |
2037385-84-3 |
C13H19ClN4O3 |
 |
N-(3,5-dimethylphenyl)picolinamide |
439591-67-0 |
C14H14N2O |
 |
Neratinib Impurity 6 |
1144516-14-2 |
C26H21ClN6O4 |
 |
Bupivacaine Impurity |
852804-30-9 |
C22H37N2O |
 |
プソイドモン酸D |
85248-93-7 |
C26H42O9 |
 |
Terazosin Impurity |
60548-08-5 |
C19H25N5O4 |
 |
1204612-29-2 |
1204612-29-2 |
C12H18ClNO2 |
 |
(S)-3-(dimethylamino)-1-(thiophen-3-yl)propan-1-ol |
1384080-56-1 |
C9H15NOS |
 |
BDJS-SH 4 |
36588-46-2 |
C12H18N2O2 |
 |
3-Chloro TirofiBan |
2713130-63-1 |
C22H35ClN2O5S |
 |
(Z)-3-(4-クロロベンジリデン)イソベンゾフラン-1(3H)-オン |
105279-16-1 |
C15H9ClO2 |
|
|
Blonanserin impurity F |
|
|
|
|
Capecitabine Impurity 9 |
|
|
|
|
Carfilzomib Impurity E |
|
|
|
|
Cefoxitin EP Impurity B |
|
|
|
|
Dabigatran Impurity 3 |
|
|
 |
Dexamethasone EP Impurity K |
1809224-82-5 |
C22H26O4 |
 |
FeBuxostat Impurity 41 |
2428631-67-6 |
C19H19N3O3S |
|
|
Formoterol Impurity 16 |
|
|
|
|
Indacaterol Impurity 11 |
|
|
|
|
Isavuconazole Impurity 14 |
|
|
|
|
Isavuconazole Impurity 19 |
|
|
 |
Isavuconazole Impurity 24 |
1176988-44-5 |
C22H17F2N5OS |
|
|
Letrozole Impurity 10 |
|
|
 |
Levofloxacin Impurity 9 |
1797099-76-3 |
C18H20FN3O4 |
 |
N-(5-Formyl-2-hydroxyphenyl)formamide |
903563-43-9 |
C8H7NO3 |
|
|
Nitrendipine Impurity 5 |
|
|
 |
Donepezil Impurity |
844694-84-4 |
C24H31NO2 |
 |
imp.E |
950781-89-2 |
C13H12F3N3O3 |
 |
Lidocaine EP Impurity |
31785-64-5 |
C12H18N2O.ClH |
 |
Prucalopride Impurity 1 |
1900715-96-9 |
C18H24ClN3O3 |
 |
3-(5-CHLOROPYRID-2-YL)CARBAMOYLPYRAZINE-2-CARBOXYLIC ACID(WXG01564) |
43200-83-5 |
C11H7ClN4O3 |
|
|
Ampicillin Impurity Q |
|
|
|
|
Cefdinir Impurity PQ(CP) |
|
|
|
|
Cefdinir Impurity IJKL |
|
|
|
|
Ceftazidime Impurity A (EP) |
|
|
|
|
Oxacillin Sodium Impurity E(EP) |
|
|
|
|
Spectinomycin Impurity B |
|
|
![8-(benzo[b]thiophen-4-yl)-5,8-diazaspiro[4.5]decan-5-ium chloride](/CAS/20180528/GIF/2143944-64-1.gif) |
8-(benzo[b]thiophen-4-yl)-5,8-diazaspiro[4.5]decan-5-ium chloride |
2143944-64-1 |
C16H21N2S+ |
 |
Ticagrelor Related Compound 14 |
2056269-94-2 |
C23H28F2N6O4S |
 |
Cefoxitin impurity E |
2395025-32-6 |
C17H19N3O8S2 |
 |
N-((4-(3-methyl-5-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide |
477594-28-8 |
C19H18N2O4S |
|
|
N-((4-(3-methyl-5-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide |
477594-28-8 |
C19H18N2O4S |
|
|
Moxifloxacin EP Impurity D HCl |
|
|
|
|
Moxifloxacin EP Impurity D HCl |
|
|
 |
Moxifloxacin Impurity 30 |
1395056-42-4 |
C21H24FN3O7 |
|
|
Moxifloxacin Impurity 30 |
1395056-42-4 |
C21H24FN3O7 |
 |
Tenofovir Impurity 37 |
161760-03-8 |
C10H15O6PS |
|
|
Tenofovir Impurity 37 |
161760-03-8 |
C10H15O6PS |
 |
Pramipexole Impurity 30 |
1802051-36-0 |
C13H24ClN3S |
|
|
Pramipexole Impurity 30 |
1802051-36-0 |
C13H24ClN3S |
 |
NZWJKTHFNLHUJO-NWZSJJIMSA-N |
1422954-12-8 |
C22H26FN3O5S |
|
|
NZWJKTHFNLHUJO-NWZSJJIMSA-N |
1422954-12-8 |
C22H26FN3O5S |
 |
LAT-NET |
607351-44-0 |
C25H39NO4 |
|
|
LAT-NET |
607351-44-0 |
C25H39NO4 |
 |
N,N-(ethane-1,2-diyl)bis(4-methyl-N-(3-((4-methylphenyl)sulfonamido)propyl)benzenesulfonamide) |
74676-47-4 |
C36H46N4O8S4 |
|
|
N,N-(ethane-1,2-diyl)bis(4-methyl-N-(3-((4-methylphenyl)sulfonamido)propyl)benzenesulfonamide) |
74676-47-4 |
C36H46N4O8S4 |
 |
L-グルコノ-1,5-ラクトン |
52153-09-0 |
C6H10O6 |
|
|
L-グルコノ-1,5-ラクトン |
52153-09-0 |
C6H10O6 |
 |
フェノフィブリン酸1-カルボキシル-1-メチルエチルエステル |
1797121-54-0 |
C21H21ClO6 |
|
|
フェノフィブリン酸1-カルボキシル-1-メチルエチルエステル |
1797121-54-0 |
C21H21ClO6 |
![2-クロロ-4'-フルオロ[1,1'-カルボニルビスベンゼン]](/CAS/GIF/1806-23-1.gif) |
2-クロロ-4'-フルオロ[1,1'-カルボニルビスベンゼン] |
1806-23-1 |
C13H8ClFO |
|
|
2-クロロ-4'-フルオロ[1,1'-カルボニルビスベンゼン] |
1806-23-1 |
C13H8ClFO |
 |
Ambrisentan Impurity E |
1312092-82-2 |
C21H18N2O3 |
|
|
Ambrisentan Impurity E |
1312092-82-2 |
C21H18N2O3 |
 |
1-(((2R,4R)-4-((Benzyloxy)methyl)-2-(2,4-difluorophenyl)tetrahydrofuran-2-yl)methyl)-1H-1,2,4-triazole |
165115-83-3 |
C21H21F2N3O2 |
![1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid](/CAS/20180629/GIF/855661-71-1.gif) |
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid |
855661-71-1 |
C21H24FN3O4 |
 |
Iopamidol Impurity K |
1788899-70-6 |
C17H23I2N3O8 |
![N-[2-(ジエチルアミノ)エチル]-2-ヒドロキシキノリン-4-カルボアミド](/CAS/20180629/GIF/87864-08-2.gif) |
N-[2-(ジエチルアミノ)エチル]-2-ヒドロキシキノリン-4-カルボアミド |
87864-08-2 |
C16H21N3O2 |
 |
5-(2-Fluorophenyl)-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-carboxylic acid |
1883595-37-6 |
C16H11FN2O4S |
 |
Ritonavir EP Impurity B |
765875-58-9 |
C28H36N4O4S |
 |
3-OXO-3-(2,4,5-TRIFLUORO-3-METHOXY-PHENYL)-PROPIONIC ACID ETHYL ESTER |
112811-68-4 |
C12H11F3O4 |
![2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-N5,N5- dimethylpyrimidine-4,5,6-triamine](/CAS/20180703/GIF/1169770-52-8.gif) |
2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-N5,N5- dimethylpyrimidine-4,5,6-triamine |
1169770-52-8 |
C19H19FN8 |
![3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one](/CAS/GIF/153139-56-1.gif) |
3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one |
153139-56-1 |
C16H20N2O |
![6-amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-
7,9-dihydro-8H-purin-8-one](/CAS/20200119/GIF/1361569-10-9.gif) |
6-amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-
7,9-dihydro-8H-purin-8-one |
1361569-10-9 |
C18H13FN8O |
|
|
Baricitinib Impurity 5 |
|
|